We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Strategic Partnership Advances Wearable Medical Devices

By HospiMedica International staff writers
Posted on 17 Nov 2014
Welch Allyn (Skaneateles Falls, NY, USA), a leading medical diagnostic device company, and Gentag (Washington DC, USA), a pioneer in disposable biosensors, have announced a strategic development agreement.

Under the terms of the agreement, Welch Allyn and Gentag will collaborate to bring to market near field communication (NFC) devices that will be integrated into medical devices and sensors. More...
The short-range wireless communication uses an antenna that is much smaller than the wavelength of the carrier signal. As a result, NFC communicates either by a modulated electric field, or a modulated magnetic field, but not by radio electromagnetic waves. For example, a small loop antenna produces a magnetic field, which can then be picked up by another small loop antenna, if it is near enough.

The partnership will enable Welch Allyn to offer solutions for remote patient monitoring worldwide by combining Gentag's NFC technology and integrated, ultrathin, battery-less wireless sensors into various medical diagnostic devices and applications. The collaboration is expected to create a range of significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record (EHR).

“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, president and CEO of Welch Allyn.

“Welch Allyn has the knowledge, expertise, and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said John Peeters, CEO of Gentag. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”

The use of wearable remote patient monitoring (RPM) biosensors that allow constant monitoring of physiological signals is becoming essential for the advancement of both the diagnosis and treatment of diseases. RPM systems allow physicians to overcome the limitations of technology and provide a response to the need for monitoring individuals over weeks or months. The data sets recorded using these systems are then processed to detect events predictive of possible worsening of the patient’s clinical situations, as well as assess the impact of clinical interventions.

Related Links:

Welch Allyn
Gentag



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Medical Monitor
VITALMAX 4100SL
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.